{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:31:01Z","timestamp":1777116661586,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtct.2022.12.023","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:50:14Z","timestamp":1672447814000},"page":"282.e1-282.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-9203","authenticated-orcid":false,"given":"Christopher E.","family":"Dandoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-2669","authenticated-orcid":false,"given":"Wan H.","family":"Tsong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushik","family":"Sarikonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-4788","authenticated-orcid":false,"given":"November","family":"McGarvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.12.023_bib0001","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2019001242","article-title":"Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort","volume":"4","author":"Schoettler","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.12.023_bib0002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bjh.16457","article-title":"Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy","volume":"189","author":"Epperla","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.12.023_bib0003","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41409-018-0293-3","article-title":"High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease","volume":"54","author":"Kraft","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.12.023_bib0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0006","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.12.023_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.12.023_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0009","unstructured":"Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Available at: www.training.cochrane.org\/handbook. Accessed May 11, 2021."},{"key":"10.1016\/j.jtct.2022.12.023_bib0010","unstructured":"National Institute for Health and Care Excellence (NICE). The guidelines manual: process and methods [PMG6]. Available at: https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/reviewing-the-evidence. Accessed May 11, 2021."},{"key":"10.1016\/j.jtct.2022.12.023_bib0039","unstructured":"Cochrane. RevMan 5. Available: https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman. Accessed July 20, 2020."},{"key":"10.1016\/j.jtct.2022.12.023_bib0040","unstructured":"Deeks JJ, Higgins JPT, Altman DG, eds. Chapter 10, Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Available: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10. Accessed June 21, 2021."},{"key":"10.1016\/j.jtct.2022.12.023_bib0011","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","article-title":"Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants","volume":"36","author":"Martinez","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029619892684","article-title":"von Willebrand factor as a predictor for transplant-associated thrombotic microangiopathy","volume":"26","author":"Xu","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtct.2022.12.023_bib0013","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0014","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.bbmt.2020.09.018","article-title":"Thrombotic microangiopathy after post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"26","author":"Imus","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.12.023_bib0016","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bbmt.2017.03.028","article-title":"Pericardial effusion following hematopoietic cell transplantation in children and young adults is associated with increased risk of mortality","volume":"23","author":"Cox","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0017","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0018","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"de Fontbrune","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.12.023_bib0019","first-page":"237","article-title":"Thrombotic microangiopathy in allogeneic stem cell transplantation in childhood","volume":"8","author":"Erbey","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy","volume":"120","author":"Gavriilaki","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtct.2022.12.023_bib0021","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","article-title":"Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation","volume":"16","author":"Glezerman","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0022","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","article-title":"Thrombotic microangiopathy afterallogeneic blood and marrow transplantation is associated with dose-intensivemyeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion","volume":"78","author":"Hahn","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.12.023_bib0023","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ajh.25922","article-title":"Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Heybeli","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.12.023_bib0024","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0025","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose carboplatin\/etoposide\/melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0026","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.12.023_bib0027","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.12.023_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0030","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.bbmt.2018.05.010","article-title":"Impact of thrombotic microangiopathy on renal outcomes and survival after hematopoietic stem cell transplantation","volume":"24","author":"Postalcioglu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0031","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pbc.22861","article-title":"Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus","volume":"57","author":"Rosenthal","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.12.023_bib0032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ejh.13127","article-title":"Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients","volume":"101","author":"Rudoni","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.12.023_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1537-2995.2003.00282.x","article-title":"Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A","volume":"43","author":"Sarkodee-Adoo","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.12.023_bib0034","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2018.08.016","article-title":"Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation-associated thrombotic microangiopathy: an institutional experience","volume":"25","author":"Sartain","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0035","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.bbmt.2018.12.840","article-title":"Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: a report of significant end-organ dysfunction in eculizumab-treated survivors","volume":"25","author":"Schoettler","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0036","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced","volume":"10","author":"Shimoni","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0037","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.bbmt.2019.06.006","article-title":"Risk factors for transplant-associated thrombotic microangiopathy after autologous hematopoietic cell transplant in high-risk neuroblastoma","volume":"25","author":"Tolbert","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.12.023_bib0038","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722018735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722018735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:08:17Z","timestamp":1721686097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722018735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666636722018735"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.12.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}